Original language | English |
---|---|
Pages (from-to) | 1747-1754 |
Journal | Clinical Cancer Research |
Volume | 3 |
Publication status | Published - 1997 |
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.
S.A.B.E. van Acker, E. Boven, K. Kuiper, D.J. van den Berg, J.A. Grimbergen, K. Kramer, A. Bast, W.J.F. van der Vijgh
Research output: Contribution to Journal › Article › Academic › peer-review